Publications

Peripheral blood mononuclear cell transcriptomic trajectories reveal dynamic regulation of inflammatory actors in delirium.

LaHue SC, Takegami N, Simmasalam R, Baqai A, Munoz E, Sikri A, de Courson TDB, Singhal NS, Eckalbar W, Langelier CR, Hendrickson CM, Calfee CS, Erle DJ, Krummel MF, Woodruff PG, Oskotsky T, Sirota M, Ferguson A, Douglas VC, Newman JC, Pleasure SJ, Wilson MR, COMET consortium, Singhal NS

2025
Compression-enabled interpretability of voxelwise encoding models.

Kamali F, Suratgar AA, Menhaj M, Abbasi-Asl R

2025
Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy.

Aikio M, Odeh HM, Wobst HJ, Lee BL, Chan Ú, Mauna JC, Mack KL, Class B, Ollerhead TA, Ford AF, Barbieri EM, Cupo RR, Drake LE, Smalley JL, Lin YT, Lam S, Thomas R, Castello N, Baral A, Beyer JN, Najar MA, Dunlop J, Gitler AD, Javaherian A, Kaye JA, Burslem GM, Brown DG, Donnelly CJ, Finkbeiner S, Moss SJ, Brandon NJ, Shorter J

2025
Reinstatement and transformation of memory traces for recognition.

Rau EMB, Fellner MC, Heinen R, Zhang H, Yin Q, Vahidi P, Kobelt M, Asano E, Kim-McManus O, Sattar S, Lin JJ, Auguste KI, Chang EF, King-Stephens D, Weber PB, Laxer KD, Knight RT, Johnson EL, Ofen N, Axmacher N

2025
Distinct Morning and Evening Fatigue Profiles in Patients With Gynecologic Cancers Receiving Chemotherapy.

Ayangba Asakitogum D, Nutor JJ, Hammer MJ, Pozzar RA, Cooper BA, Paul SM, Conley YP, Levine JD, Miaskowski C

2025
Challenges and opportunities for advancing functional MRI in clinical practice.

Voets NL, Price CJ, Glasser MF, Benjamin C, Rutten GJ, Plaha P, Benzinger T, Mian A, Gawryluk J, Pernet C, Jones OP, Haller S, Sierpowska J, Talib G, Binder J, Williams L, Jovicich J, Zeineh M, Ashtari M, Shimony J, Polczynska-Bletsos M, Bizzi A, Chang EF, Scheel M, Bjornson B, Nicols T, Beckmann CF, Geletneky K, Bookheimer S, Bartsch AJ

2025
Distributed intracranial activity underlying human decision-making behavior.

Overton JA, Moxon KA, Stickle MP, Peters LM, Lin JJ, Chang EF, Knight RT, Hsu M, Saez I

2025
Correction to: Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab.

VandeVrede L, La Joie R, Horiki S, Mundada NS, Koestler M, Hwang JH, Ljubenkov PA, Rojas JC, Rabinovici GD, Boxer AL, Seeley WW

2025
Greater Symptom Burden and Poorer Quality of Life Outcomes Are Associated With The Co-Occurrence of Anxiety and Depression During Cancer Chemotherapy.

Calvo-Schimmel A, Hammer MJ, Conley YP, Paul SM, Cooper BA, Shin J, Harris C, Morse L, Levine JD, Miaskowski C

2025

Pages